Julie Appleby

Kaiser Health News; Karl Gelles, USA TODAY; Jim Sergent, USA TODAY

The path of prescription drugs from the factory to the patient is complicated. Here, Julie Appleby of Kaiser Health News explains how money flows through the system and contributes to the cost of a 30-day supply of a hypothetical brand-name medicine.